METTL3通过FGF2/PI3K/AKT/mTOR途径影响肺腺癌的生物功能
Shaoting Chen1,2, Xiuqing Shen2, Pengju Cao2
1Department of Clinical Laboratory, Fujian Medical University Union Hospital, Fuzhou, China.
Frontiers in oncology
|November 5, 2024
概括
在肺腺癌 (LUAD) 中,METTL3因子受到下调,促进瘤生长. 准FGF2和PI3K/AKT/mTOR通路为LUAD提供了新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
背景情况:
- 肺腺癌 (LUAD) 是癌症相关死亡的主要原因.
- 在癌症进展中RNA修饰的作用,特别是N6-甲基氨酸 (m6A),是一个新兴的研究领域.
- METTL3是一种关键的m6A甲基转移酶,在各种癌症中具有潜在的作用.
研究的目的:
- 为了研究m6A调节因子METTL3在LUAD中的功能.
- 阐明METTL3影响LUAD进展的分子机制.
- 在LUAD中识别由METTL3规范的下游目标和信号通路.
主要方法:
- 在LUAD组织和细胞系中分析METTL3表达.
- 细胞功能实验评估的增殖,迁移和入侵.
- mRNA测序 (mRNA-seq) 和m6A个人核酸分辨率交叉链接和免疫沉降 (MeRIP-qPCR) 以确定目标基因.
- 西方模糊测试以评估信号通路的激活.
主要成果:
- 与正常组织相比,LUAD中的METTL3表达显著下调.
- 低调METTL3促进LUAD细胞的增殖,迁移和入侵.
- METTL3负面调节纤维细胞生长因子2 (FGF2) 表达,并增强FGF2mRNA的稳定性.
- 抑制FGF2可以逆转METTL3下调的促进瘤效应.
- 抑制METTL3导致PI3K/AKT/mTOR信号通路活动减少,而FGF2沉默则会逆转这种情况.
结论:
- 在LUAD中,METTL3作为瘤抑制剂起作用.
- 通过METTL3调节FGF2,影响LUAD细胞的行为和信号传递.
- METTL3/FGF2/PI3K/AKT/mTOR轴代表了LUAD进展中的一个新的监管网络.
- 这些发现表明潜在的治疗策略针对METTL3 / FGF2途径用于LUAD治疗.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.9K
06:54Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
12.8K
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
mTOR Signaling and Cancer Progression
3.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.7K
Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
MAPK Signaling Cascades
5.2K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.2K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
